Founded in 2016, the company has received a $16.00M Venture Round investment as of 20 September 2023. Their cutting-edge technologies, including novel sample preparation methods and machine learning algorithms, enable ultra-high enrichment of pathogen DNA for rapid sequencing directly from clinical samples. Day Zero's fast, accurate, and comprehensive diagnostics not only improve patient outcomes but also result in substantial cost savings in healthcare. With a focus on biotechnology and healthcare, the United States-based company is addressing a critical unmet need in the medical field.
Day Zero Diagnostics, Inc
The future of infectious disease diagnostics starts at Day Zero.
Founded 2016
Boston, United States
64 employees
Unknown
Total: $63.00M
Biotechnology, Health Care +1
Boston, United States
64 employees
Unknown
Total: $63.00M
Biotechnology, Health Care +1
General Information
Get notified when Day Zero Diagnostics, Inc moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Day Zero Diagnostics, Inc
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
United States Market
Biotechnology
About Day Zero Diagnostics, Inc
Taxonomy: infectious disease diagnostics, whole-genome sequencing, in-vitro diagnostics, clinical data analysis, machine learning algorithms, pathogen DNA enrichment, antibiotic resistance profiling, sepsis diagnostics, clinical sample preparation, real-time sequencing, drug efficacy profiling, biomedical innovation, precision medicine, healthcare cost savings
Funding Rounds & Investors (12)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Early VC | •••••• | - | 01 Sep 2023 | |
| Grant | •••••• | 1 |
|
01 Oct 2022 |
| Early VC | •••••• | 5 |
|
01 Feb 2022 |
| Unknown | •••••• | - | 01 Dec 2020 | |
| Grant | •••••• | 1 |
|
01 May 2020 |
Day Zero Diagnostics, Inc Alternatives & Competitors
Day Zero Diagnostics, Inc vs
Day Zero Diagnostics, Inc vs
EDX Medical Group
United Kingdom
Developing innovative diagnostics to enable personalised treatment for cancer, heart disease and inf...
Seed
12 employees
Health Care, Medical Devices
Day Zero Diagnostics, Inc vs
Selux Diagnostics, Inc
United States
Precision diagnostics for infectious disease.
Series D
95 employees
Biotechnology, Health Care
FAQ About Day Zero Diagnostics, Inc
The future of infectious disease diagnostics starts at Day Zero.
Day Zero Diagnostics, Inc was founded in 2016.
Day Zero Diagnostics, Inc is headquartered in Boston, United States.
Day Zero Diagnostics, Inc operates in the following industries: Biotechnology, Health Care, Medical Devices.
Day Zero Diagnostics, Inc has approximately 64 employees.
Day Zero Diagnostics, Inc has completed 12 funding rounds, raising a total of $63.00M. The latest funding stage is Unknown.
Top alternatives and competitors to Day Zero Diagnostics, Inc include Qvella Corporation, EDX Medical Group, Selux Diagnostics, Inc, GenomeScan, Proactive Diagnostics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Day Zero Diagnostics, Inc and Qvella Corporation are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Don't just browse. Track.
Signal Tracker monitors Day Zero Diagnostics, Inc and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.